Abstract
This application relates to a novel crystalline form of 6-[(6,7-dimethoxy quinazolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide, also known as Fruquintinib. The disclosure also covers the process for preparing this new crystalline form.
Formula-1.
The present disclosure also relates to a process for the preparation of compound of formula-9 which is a key intermediate used in the preparation of Fruquintinib.
Formula-9
The present disclosure also relates to a process for the preparation of Fruquintinib.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Gade Srinivas Reddy; Kammari Balraju; Bingi Hariprasad Reddy; Padigapaty Shiva Reddy and Matapathi Mahesh., "Novel crystalline form of 6-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N,2- dimethyl-1-benzofuran-3-carboxamide and its process for the preparation", Technical Disclosure Commons, (October 27, 2025)
https://www.tdcommons.org/dpubs_series/8795